Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatorenal Syndrome-acute Kidney Injury (HRS-AKI) Treatment With Transjugular Intrahepatic Portosystemic Shunt in Patients With Cirrhosis. A Randomized Controlled Trial

NCT05346393 is registered in ClinicalTrials.gov with Jena University Hospital as lead sponsor.

NCT NCT05346393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05346393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatorenal Syndrome-acute Kidney Injury (HRS-AKI) Treatment With Transjugular Intrahepatic Portosystemic Shunt in Patients With Cirrhosis. A Randomized Controlled Trial
Lead sponsor
Jena University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
November 29, 2022
Completion date
June 30, 2026
Enrollment
124 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, ascites hepatic, cirrhosis, liver, hepatorenal syndrome